54.88 
0.17(0.31%) 3:11PM EDT - Nasdaq Real Time Price
| Prev Close: | 55.05 |
|---|
| Open: | 55.06 |
|---|
| Bid: | 54.93 x 300 |
|---|
| Ask: | 54.95 x 900 |
|---|
| 1y Target Est: | 68.56 |
|---|
| Beta: | 1.07 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 54.83 - 55.86 |
|---|
| 52wk Range: | 33.03 - 55.86 |
|---|
| Volume: | 945,379 |
|---|
| Avg Vol (3m): | 2,580,710 |
|---|
| Market Cap: | 145.25B |
|---|
| P/E (ttm): | 27.08 |
|---|
| EPS (ttm): | 2.03 |
|---|
| Div & Yield: | 1.30 (2.40%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Regeneron and Sanofi: An Unstoppable Biotech Duo?at Motley Fool(Tue, May 21)
- New Drug May Help Some Asthmatics, Study Findsat New York Times(Tue, May 21)
- Elan Continues To Make Baffling Strategic Decisionat Investopedia(Tue, May 21)
- Will Influenza A H7N9 Generate Opportunities For Pharma?at Seeking Alpha(Tue, May 21)
- New Asthma Drug Generates Excitement For Patients -- And Its Makerat Forbes(Tue, May 21)
- Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of MedicinePR Newswire(Tue, May 21)
- Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Global ConsolidationBusiness Wire(Tue, May 21)
- Sanofi (SNY): Today's Featured Drugs Laggardat TheStreet(Mon, May 20)
- 5 Stocks Underperforming Today In The Drugs Industryat TheStreet(Mon, May 20)
- Catalyst Pharmaceutical's CPP-115 May Be Big Pipeline In Just One Little Pillat Seeking Alpha(Mon, May 20)
- Too Many Questions Make This Thursday Mover a Sellat Motley Fool(Mon, May 20)
- 1 Great Dividend You Can Buy Right Nowat Motley Fool(Sun, May 19)
- Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Startedat Motley Fool(Sun, May 19)
- Will ASCO Unlock Big Value in This Cancer Drug Class?at Motley Fool(Sat, May 18)
- This Week in Biotechat Motley Fool(Sat, May 18)
Key Statistics
| Forward P/E (1 yr): | 12.81 |
|---|
| P/S (ttm): | 3.20 |
|---|
| Ex-Dividend Date: | 06-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.76 |
|---|
| Quarterly EPS Est
(Mar-13)
: | N/A |
|---|
| Mean Recommendation*: | 1.5 |
|---|
| PEG Ratio (5 yr expected): | 2.08 |
|---|
Business Summary
Sanofi researches, develops, manufactures, and markets healthcare products worldwide. The company operates through Pharmaceuticals, Human Vaccines, and Animal Health segments.
View More